Dr Alexandra Stewart is a Consultant Clinical Oncologist with a special interest in pelvic cancer and brachytherapy. She qualified in 1997 and trained at Charing Cross and the Royal Marsden Hospitals with a Fellowship at Harvard University in Boston. Her clinical interests include the improvement of radiotherapy dose delivery in pelvic cancer, using conformal radiotherapy and/or brachytherapy. Alex joined the BIR because she liked the idea of joining a multi-disciplinary group which has a focus on education and networking with staff groups that no other organisation provides her the forum for.

Dr. Keith Langmack is Head of Radiotherapy Physics at Nottingham University Hospitals NHS Trust. He started his career in radiotherapy physics at Addenbrooke’s Hospital, Cambridge in 1989 after completing his B.Sc. in physics in Durham (1982-85) and D.Phil. in molecular biophysics at Queen’s College, Oxford (1985-89). He moved to Lincoln in 2000 and then Nottingham in 2002. He is a Fellow of IPEM and a Charted Scientist. He has many scientific papers across diverse topics within radiotherapy. His current special interests are in imaging in radiotherapy and optimising radiotherapy workflows.

Scott Hanvey began working as a medical physicist in 2005 and completed his PhD in 2014 on using MRI to improve structural localisation in radiotherapy at the University of Glasgow. In his current role he is working as the Lead Radiotherapy Planning Physicist at the Radiotherapy Unit in Hampshire Hospitals Foundation Trust. Here he primarily provides medical physics support in radiotherapy planning.

Sheila Hassan is the Sanctioning Lead Radiographer at Guy’s andSt Thomas’ Foundation Trust and was President of the SCoR 2015-16.  Sheila trained at Guy’s hospital in 1976-1978 and upon qualification worked at the then University College Hospital. Sheila left the profession to raise a family for 19 years and returned in 1999. She has been an active member of the SCoR since 2003 as a union rep and represents member’s interest on a range of Trust committees in relation to pay and conditions. More recently with her role on UK council she represents all members’ interests and is keen to raise the profile of radiographers in all suitable forums. Sheila has a passion for training and education and in her role in the Londonregion helps organise study days for radiographers.

Sam Tudor is Head of QC and Dosimetry in the Radiotherapy Physics section at University Hospitals Birmingham. He started his career at Addenbrooke’s Hospital in Cambridge, where he helped support the Tomotherapy service while studying for a PhD in the effect of geometric uncertainties on treatment success. He has interests in the use of radiobiological modelling to inform the effect of geometric uncertainties and imaging strategies, as well as the dosimetry of complex, small or unflattened beams. 

Helen Best and Úna Findlay (PHE) The radiotherapy team at PHE are an independent resource for the radiotherapy community with the goal of improving patient safety and efficiency in radiotherapy within the context of legislation.  This involves the analysis of radiotherapy error and near miss events (RTE) and promulgation of learning across the community; the provision of independent on-site support to individual departments; work with professional bodies to provide guidance on good practice; the provision of support to inspectorates and Department of Health and liaison with UK professional bodies & international organisations. Helen Best is the editor of the radiotherapy newsletter “Safer Radiotherapy”, which disseminates learning from the analysis of RTE. Helen is an experienced therapy radiographer who joined the Health Protection Agency (HPA), in 2012. HPA merged into Public Health England (PHE) in April 2013, where the work of the radiotherapy team continues. Úna Findlay joined the HPA in 2007 as part of an initiative by the Chief Medical Officer to improve patient safety in radiotherapy. Úna is the current Chair of the Patient Safety in Radiotherapy Steering Group (PSRT) which is tasked with taking the key recommendations of Towards Safer Radiotherapy forward and an invited member of the Radiotherapy Board.

Anne Gasnier is a radiotherapy physicist at The Royal Marsden Hospital. After working in industry in ultrasound for 4 years, she completed the Clinical Scientist Training at King's College Hospital and did her elective placement in protontherapy at the Paul Scherrer Institute (Switzerland). She gained an MSc in Medical Physics (Distinction) at King's College London and a Master's degree in Engineering from Ecole Centrale Paris (France).

Shaista Hafeez is a medical doctor who graduated from Imperial College School of Medicine. She completed higher specialist training in Clinical Oncology in 2016 with the London Dearnery during which she pursued further clinical research interests, completing an MSc and subsequently a CRUK funded PhD at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research investigating advanced radiotherapy techniques and functional MRI to improve patient outcomes.

Mania Aspradakis is a state registered clinical scientist practising in radiation therapy. After a PhD on photon dose calculation algorithms at Edinburgh University she completed the IPEM higher training in radiotherapy physics at the Regional Medical Physics department at Newcastle upon Tyne. She moved to Switzerland to be closer to higher mountains and while living there she has worked in the public as well as the private sector as a medical physicist. Over the years she regularly contributes to the work of scientific/professional societies; for IPEM as a member of RT-SIG and two working parties, for ESTRO School as a teacher and for AAPM and SSRMP as task group member. She contributes to IAEA missions as an expert consultant. Her current scientific interests include dose modelling, radiation dosimetry and the clinical implementation of new radiotherapy technology.

 

 

 


 

British Institute of Radiology - Cookie Disclaimer

The British Institute of Radiology website uses cookies to provide you with essential online features. If you continue to use our site without changing your browser settings, we'll assume you are happy to receive cookies. Please read our Cookie policy for more information.